AnGes, Inc.

AnGes, Inc.verified

AMGXF

Price:

$0.3602

Market Cap:

$25.48B

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and disc degeneration; medical devices for the prevention of vascular restenosis; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative r...[Read more]

Industry

Biotechnology

IPO Date

2017-07-03

Stock Exchange

OTC

Ticker

AMGXF

The Enterprise Value as of December 2025 (TTM) for AnGes, Inc. (AMGXF) is 22.77B

According to AnGes, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 22.77B. This represents a change of 45.16% compared to the average of 15.69B of the last 4 quarters.

AnGes, Inc. (AMGXF) Historical Enterprise Value (quarterly & annually)

How has AMGXF Enterprise Value performed in the past?

The mean historical Enterprise Value of AnGes, Inc. over the last ten years is 35.98B. The current 22.77B Enterprise Value has changed 6.23% with respect to the historical average. Over the past ten years (40 quarters), AMGXF's Enterprise Value was at its highest in in the June 2020 quarter at 226.71B. The Enterprise Value was at its lowest in in the September 2015 quarter at 7.60B.

Quarterly (TTM)
Annual

Average

35.98B

Median

20.32B

Minimum

9.16B

Maximum

136.81B

AnGes, Inc. (AMGXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AnGes, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 209.74%

Maximum Annual Enterprise Value = 136.81B

Minimum Annual Increase = -76.30%

Minimum Annual Enterprise Value = 9.16B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202411.04B12.28%
20239.83B7.33%
20229.16B-76.30%
202138.65B-71.75%
2020136.81B140.51%
201956.88B120.64%
201825.78B-44.01%
201746.04B209.74%
201614.87B38.77%
201510.71B32.34%

AnGes, Inc. (AMGXF) Average Enterprise Value

How has AMGXF Enterprise Value performed in the past?

The current Enterprise Value of AnGes, Inc. (AMGXF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

10.01B

5-year avg

41.10B

10-year avg

35.98B

AnGes, Inc. (AMGXF) Enterprise Value vs. Peers

How is AMGXF’s Enterprise Value compared to its peers?

AnGes, Inc.’s Enterprise Value is greater than Faron Pharmaceuticals Oy (252.38M), greater than Adocia S.A. (140.80M), greater than Recce Pharmaceuticals Ltd (178.17M), greater than Planet 13 Holdings Inc. (102.72M), greater than Newron Pharmaceuticals S.p.A. (421.53M), greater than Volpara Health Technologies Limited (284.13M), greater than Ascentage Pharma Group International (20.23B), greater than Eupraxia Pharmaceuticals Inc. (187.98M), greater than EKF Diagnostics Holdings plc (95.43M), less than Prescient Therapeutics Limited (0),

Build a custom stock screener for AnGes, Inc. (AMGXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnGes, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AnGes, Inc. (AMGXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AnGes, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AnGes, Inc.'s Enterprise Value?

What is the highest Enterprise Value for AnGes, Inc. (AMGXF)?

What is the 3-year average Enterprise Value for AnGes, Inc. (AMGXF)?

What is the 5-year average Enterprise Value for AnGes, Inc. (AMGXF)?

How does the current Enterprise Value for AnGes, Inc. (AMGXF) compare to its historical average?